Quote For Cell Therapeutics, Inc. CTIC.O
Cell Therapeutics, Inc. (CTIC.O) (Consolidated Issue listed on NASDAQ Capital Market)
sector: Healthcare ·
industry: Biotechnology ·
$1.11
27 Nov 2009
+0.91%
$1.10
$1.04
9,024,524
$1.12
$1.04
$2.23
$0.05
7.07
8,299,171
News
Press Releases
Key Developments
Officers
| Name | Current Position | Compensation |
|---|---|---|
| Nudelman, Phillip | Chairman of the Board | -- |
| Bianco, James | Chief Executive Officer, Director | 2,065,322 |
| Philips, Craig | President | 282,142 |
Key Ratios and Statistics
| Share Related Items | |
|---|---|
| Market Cap (Mil.) | $637.61 |
| Shares Outstanding (Mil.) | 574.43 |
| Float (Mil.) | 559.00 |
| Dividend Information | |
|---|---|
| Yield % | -99,999.99 |
| Annual Dividend ($ USD) | 0.00 |
| Payout Ratio(TTM) % | -- |
| Financial Strength | |
|---|---|
| Quick Ratio | 0.67 |
| Current Ratio | 0.82 |
| LT Debt/Equity | -- |
| Total Debt/Equity | -- |
| Valuation Ratios | |
|---|---|
| Price/Earnings(TTM) | -- |
| Price/Sales(TTM) | 244.48 |
| Price/Book(TTM) | -- |
| Price/Cash Flow(TTM) | -- |
| Per Share Data | |
|---|---|
| Earnings(TTM) | $-0.71 |
| Sales(TTM) | $0.01 |
| Book Value(MRQ) | $-0.02 |
| Cash Flow(TTM) | $-0.38 |
| Cash(MRQ) | $0.10 |
| Management Effectiveness | |
|---|---|
| Return on Equity(TTM) | -- |
| Return on Assets(TTM) | -117.66 |
| Return on Investment(TTM) | -310.50 |
| Margins | |
|---|---|
| Gross Margin(TTM) % | 65.68 |
| Operating Margin(TTM) % | -2,874.73 |
| Profit Margin(TTM) % | -4,083.86 |
Market Update
UK
US- Europe
- Asia
- UK Most Actives
advertisement
